{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:52:51Z","timestamp":1784155971684,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AR058005"],"award-info":[{"award-number":["AR058005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK10093"],"award-info":[{"award-number":["DK10093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IUSM-CTSI training","award":["TR001107"],"award-info":[{"award-number":["TR001107"]}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bone.2015.04.021","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T23:47:09Z","timestamp":1429314429000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions"],"prefix":"10.1016","volume":"77","author":[{"given":"Christopher L.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2015.04.021_bb0005","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-011-1781-0","article-title":"Fracture risk assessment in patients with chronic kidney disease","volume":"23","author":"Jamal","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0010","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2015.04.021_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","article-title":"Renal function and risk of hip and vertebral fractures in older women","volume":"167","author":"Ensrud","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bone.2015.04.021_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2015.04.021_bb0025","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0030","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","article-title":"A structural approach to renal bone disease","volume":"13","author":"Parfitt","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1359\/jbmr.2006.21.2.307","article-title":"Cortical and trabecular load sharing in the human vertebral body","volume":"21","author":"Eswaran","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0040","doi-asserted-by":"crossref","first-page":"e110057","DOI":"10.1371\/journal.pone.0110057","article-title":"The effect of naturally occurring chronic kidney disease on the micro-structural and mechanical properties of bone","volume":"9","author":"Shipov","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2015.04.021_bb0045","doi-asserted-by":"crossref","first-page":"e99262","DOI":"10.1371\/journal.pone.0099262","article-title":"Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease","volume":"9","author":"Newman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2015.04.021_bb0050","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bone.2011.03.672","article-title":"Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease","volume":"48","author":"Iwasaki","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.021_bb0055","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00198-012-2103-x","article-title":"Skeletal effects of zoledronic acid in an animal model of chronic kidney disease","volume":"24","author":"Allen","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0060","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/labinvest.2013.105","article-title":"Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy","volume":"93","author":"Aoki","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.bone.2015.04.021_bb0065","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jbmr.2089","article-title":"A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD","volume":"29","author":"Moe","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0070","first-page":"865","article-title":"Modification of disease progression in rats with inherited polycystic kidney disease","volume":"27","author":"Cowley","year":"1996","journal-title":"Yajkd"},{"key":"10.1016\/j.bone.2015.04.021_bb0075","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.1993.79","article-title":"Autosomal-dominant polycystic kidney disease in the rat","volume":"43","author":"Cowley","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0085","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ng.2681","article-title":"ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3","volume":"45","author":"Hoff","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.bone.2015.04.021_bb0090","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1681\/ASN.2013060646","article-title":"Mutations in ANKS6 cause a nephronophthisis-like phenotype with ESRD","volume":"25","author":"Taskiran","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2015.04.021_bb0095","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1681\/ASN.2005060601","article-title":"Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy\/+) rat","volume":"16","author":"Brown","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bone.2015.04.021_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0110","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.021_bb0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0125","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0130","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","article-title":"In elderly men and women treated for osteoporosis a low creatinine clearance of <65ml\/min is a risk factor for falls and fractures","volume":"16","author":"Dukas","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2015.04.021_bb0140","article-title":"Bone biopsy in renal osteodystrophy","volume":"1","author":"Christov","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.bone.2015.04.021_bb0145","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.V491631","article-title":"The role of bone biopsy in the management of patients with renal osteodystrophy","volume":"4","author":"Malluche","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2015.04.021_bb0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.semnephrol.2009.01.005","article-title":"Bone histomorphometry in renal osteodystrophy","volume":"29","author":"Ott","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.bone.2015.04.021_bb0155","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/039139880402701103","article-title":"Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy","volume":"27","author":"Spasovski","year":"2004","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.bone.2015.04.021_bb0160","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2015.04.021_bb0165","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2015.04.021_bb0170","article-title":"Why bones bend but don't break","volume":"11","author":"Burr","year":"2011","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.bone.2015.04.021_bb0175","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0180","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2015.04.021_bb0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2015.04.021_bb0190","first-page":"671","article-title":"Evaluating bone quality in patients with chronic kidney disease","volume":"9","author":"Malluche","year":"2013","journal-title":"Nat Publ Group"},{"key":"10.1016\/j.bone.2015.04.021_bb0195","series-title":"Changes in skeletal collagen crosslinks and matrix hydration in high and low turnover chronic kidney disease","first-page":"1","year":"2014"},{"key":"10.1016\/j.bone.2015.04.021_bb0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.021_bb0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","article-title":"Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know","volume":"49","author":"Allen","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.021_bb0210","article-title":"Five years of anti-resorptive activity after a single dose of zoledronate \u2014 results from a randomized double-blind placebo-controlled trial","volume":"1\u20135","author":"Grey","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2015.04.021_bb0215","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/jbmr.438","article-title":"A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5years","volume":"26","author":"Reid","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.bone.2015.04.021_bb0220","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1359\/jbmr.080501","article-title":"Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats","volume":"23","author":"Fuchs","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2015.04.021_bb0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0300-483X(03)00257-9","article-title":"The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats","volume":"191","author":"Pfister","year":"2003","journal-title":"Toxicology"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T11:56:09Z","timestamp":1651751769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328215001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"alternative-id":["S8756328215001349"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2015.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}